Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Optimal Sequencing Determination for Relapsed Multiple Myeloma

Multiple Myeloma

Clinical Outcomes of Patients with KRAS G12C Mutant Non-Small Cell Lung Cancer: An ATOMIC Consortium Analysis

Multiple Cancer Types

Open-Label, Multicenter, Phase 1 Study to Assess the Safety of P-BCMA-101 in Subjects with Relapsed / Refractory Multiple Myeloma (MM) Followed by a Phase 2 Assessment of Response and Safety (PRIME)

Multiple Myeloma

Prospective Validation of a Venous Thrombosis Risk Assessment Model in Critically Ill Children from the CHAT Registry

Hematologic

An Observational Retrospective Cohort Study of Systemic Therapies for Relapsed or Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL), to Compare Outcomes to Those from Tafasitamab + Lenalidomide in the L-MIND Study

Lymphoma

Biomarker Analysis of Breast Cancer Patients Receiving Immunotherapy

Breast

Patient and Health Care Provider Perspectives of Naloxone

Miscellaneous

Pattern of Changes in Immune Profile in the Setting of Chimeric Antigen Receptor T-Cell Therapy

Miscellaneous

Barriers & Facilitators to Hispanic Participation in Cancer Clinical Trials

Disposable Perfusion Phantom for Accurate DCE-MRI Measurement of Pancreatic Cancer Therapy Response

Pancreatic